HOME   |    PDF   |   


Title

Salivary oxidative stress biomarkers across oral submucous fibrosis stages among Indian patients

 

Authors

Satish Bhosale1, Gargi Nimbulkar2,*, Archana Gaikwad2, Prachurya Dakshinakabat3, Priyanka Mahale4 & S. Prasanna5

 

Affiliation

1Department of Oral & Maxillofacial Pathology & Oral Microbiology, Bharati Vidyapeeth Dental College & Hospital, Sangli, Maharashtra, India; 2Department of Dentistry, Government Medical College & Hospital, Miraj, Dist-Sangli, Maharashtra, India; 3Department of Oral & Maxillofacial Pathology & Oral Microbiology, Geetanjali Dental & Research Institute, Geetanjali University, Udaipur, Rajasthan, India; 4Department of Prosthodontics and Crown & Bridge, SDM College of Dental Sciences and Hospital, Dharwad, Karnataka, India; 5Department of Oral & Maxillofacial Pathology & Oral Microbiology, Seema Dental College & Hospital, Rishikesh, Uttarakhand, India; *Corresponding author

 

Email

Satish Bhosale - Email: drsatish.bhosale@gmail.com
Gargi Nimbulkar - Email: garginimbulkar@gmail.com; Phone: +91 9421703449
Archana Gaikwad - Email: archana.gaik71@gmail.com
Prachurya Dakshinakabat - Email: prachurya143@gmail.com
Priyanka Mahale - Email: drpriyankamahale@gmail.com
S. Prasanna - Email: dr.prasanna1oralpath@gmail.com

 

Article Type

Research Article

 

Date

Received September 1, 2026; Revised September 30, 2026; Accepted September 30, 2026, Published September 30, 2026

 

Abstract

Oral submucous fibrosis is a chronic potentially malignant disorder in which clinical staging is mainly based on mouth opening and fibrotic bands, while non-invasive biochemical indicators of disease severity remain insufficiently used. Therefore, it is of interest to evaluate the salivary malondialdehyde, 8-hydroxy-2-deoxyguanosine, superoxide dismutase, catalase and total antioxidant capacity in 120 participants, including 80 clinically staged oral submucous fibrosis patients and 40 healthy controls. Unstimulated whole saliva was collected under standardized morning conditions, biomarkers were measured by enzyme-linked and colorimetric assays and clinical staging was performed using interincisal mouth opening, burning sensation score and palpable fibrotic band distribution. Mean salivary malondialdehyde increased from 2.18 ± 0.64 micromol/L in controls to 6.41 ± 1.32 micromol/L in stage III disease, while total antioxidant capacity declined from 1.42 ± 0.31 to 0.72 ± 0.22 mmol/L; oxidative markers correlated negatively with mouth opening and positively with clinical stage (p < 0.001). Thus, data shows that a salivary oxidative stress panel can provide a practical adjunct for staging and monitoring oral submucous fibrosis.

 

Keywords

Oral submucous fibrosis, saliva, malondialdehyde, 8-OHdG, antioxidant capacity, clinical staging

 

Citation

Bhosale et al. Bioinformation 22(9): 5621-5625 (2026)

 

Edited by

Ashwini Dhopte

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.